AlphAIAlphAI — Financial news for AI agents
stocktwits.comAUG 202 min read$OSCR

OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance

Oscar Health (OSCR) shares rose 12% to a 5-year high after the company reported strong Q1 earnings and optimistic guidance for 2026. CFO Scott Blackley cited favorable industry trends and potential upside to guidance, with membership growing 56% year-over-year to 3.17 million. The company's medical loss ratio improved to 70.5% from 75.4%. OSCR stock has gained 78% over the past year.

Original reporting
stocktwits.com
Published Aug 20, 2026, 9:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 2:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$OSCR
Bullish
high confidence
Mentioned
$OSCR
Relevance
7/10
AlphAI data visualization · based on stocktwits.com
Decision brief

The 30-second read

$OSCRBullishHigh
01

Why it matters

Earnings beat and forward guidance suggest near‑term upside, but revenue shortfall and policy risk remain.

02

Market read

The earnings surprise and optimistic guidance are driving a notable intraday rally, making OSCR a short‑term trade candidate.

03

What to watch

Potential regulatory changes to ACA subsidies and competitive exits may affect long‑term growth.

Relevance 7/10Novelty 8/10Timing: Monday

Background

Oscar Health highlighted strong membership growth and improved medical loss ratio while acknowledging ACA market challenges.

Company-level read

Ticker impact

$OSCRBullishHigh confidence
Context

Oscar Health reported Q1 EPS $2.07 vs $1.10 estimate and announced upbeat 2026 guidance, driving a 12% stock jump.

Expected impact

Expect continued buying pressure; price may test next resistance around $8‑$9.

Evidence & confidence

Earnings beat, revenue miss offset by membership growth and improved loss ratio; management cites healthy tailwinds.

Market effects

Sector

Positive outlook may lift other ACA insurers as competitors exit the market.

Regional

U.S. health‑insurance sector could see modest gains.

Global

Limited to U.S. market; no direct global impact.

Counterpoint

What could challenge this read

Revenue miss and ACA market contraction could pressure margins if member churn rises.

Key entities

  • company
    Oscar Health

    U.S. health‑insurance provider listed as OSCR.

  • executive
    CFO Scott Blackley

    Provided commentary on earnings and 2026 outlook.

Read at source← All news

Related articles

SEP 16
$OSCRHighAI 8/10

OSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises

Oscar Health (OSCR) revised its 2026 forecasts, raising operating earnings outlook by $100M to $600M-$800M and improving medical loss ratio guidance. Revenue guidance remains $18.7B-$19B. GF Value™ indicates OSCR is 33.9% overvalued at $32.44. The company has a strong GF Score™ of 83/100, with high growth and momentum ratings but middling profitability and valuation. Insiders have sold significantly more shares than they've bought.

gurufocus.com2 min
SEP 16
$OSCRHighAI 8/10

Oscar Health boosts 2026 earnings outlook, affirms revenue

Oscar Health (OSCR) updated its 2026 earnings outlook, lowering its Medical Loss Ratio to 81.0%-82.0% and raising earnings from operations to $600M-$800M. The company reaffirmed revenue guidance of $18.7B-$19.0B and maintained SG&A expense ratio targets. The updates will be discussed at its 2026 Investor Day on September 16, 2026.

tipranks.com2 min
SEP 16
$OSCRHighAI 8/10

Oscar Health raises FY26 earnings guidance by $100 million

Oscar Health (OSCR) raised its 2026 earnings guidance by $100 million, citing improved cost controls. The company expects earnings from operations to range from $600 million to $800 million, with a medical loss ratio of 81.0% to 82.0%. Total revenue guidance remains unchanged at $18.7 billion to $19.0 billion. The stock has gained 85.57% over the past year, reaching a 52-week high of $27.59.

scanx.trade2 min
SEP 5
$CNCMed

CNC, OSCR Stocks Rally After Baird Calls Risk Adjustment Results Favorable

Centene (CNC) and Oscar Health (OSCR) shares rose 6% and 12% respectively after Baird reported favorable risk adjustment results. Baird noted the outcomes support Centene's Q4 commentary and align with Oscar's June investor conference remarks. Molina (MOH) shares also rose 2% despite a minor negative impact. The Centers for Medicare & Medicaid Services released final 2025 risk adjustment data on June 30, affecting insurers' earnings.

stocktwits.com2 min